MétaCan
Menu
Back to cohort
Record W4411325124 · doi:10.1038/s41746-025-01572-8

Exploratory digital outcome measures of motor sign progression in Parkinson’s disease patients treated with prasinezumab

2025· article· en· W4411325124 on OpenAlexaff
Kirsten I. Taylor, Florian Lipsmeier, Marzia A. Scelsi, Ekaterina Volkova-Volkmar, Daria Rukina, Werner Popp, Stefan Lambrecht, Judith Anzures‐Cabrera, David Summers, Markus Abt, Annabelle Monnet, Timothy Kilchenmann, Jens Schjodt‐Eriksen, Laurent Essioux, Thomas Kustermann, Wagner Zago, Hanno Svoboda, Tania Nikolcheva, Ronald B. Postuma, Gennaro Pagano, Michael Lindemann, Claudia Altendorf, Solène Ansquer, Raphaele Arrouasse, Sana Aslam, Jean-Philippe Azula, Jeanette Baker, Ernest Balaguer Martinez, Shadi Barbu, Kara Bardram, Danny Bega, H. Marco, Isabelle Bénatru, Eve Benchetrit, Felix Bernhard, Aris Raad Besharat, Sagari Betté, Amélie Bichon, Andrew Billnitzer, Sophie Blondeau, Thomas Boraud, Friederike Borngräber, James T. Boyd, Kathrin Brockmann, Matthew Brodsky, Ethan Brown, Christof Bruecke, Fabienne Calvas, Monica Canelo, Federico Carbone, Laura Casado‐Fernández, Catherine Casse-Parrot, Anna Castrioto, Hélène Catalá, Justine Chan, Samia Cheriet, Anthony Ciabarra, Joseph Claßen, Juliana Coleman, Robert R. Coleman, Yaroslau Compta, Jean-Christophe Corvol, Nabila Dahodwala, Philippe Damier, Elodie David, Thomas L. Davis, Marissa Dean, Bérengère Debilly, Janell DeGiorgio, Andres Deik, Laure Delaby, Marie-Helene Delfini, Pascal Derkinderen, Philippe Derost, María de Toledo, Lisa M. Deuel, Cameron Dietiker, Karina Dimenshteyn, Julio Dotor, Franck Durif, Jens Ebentheuer, Karla Eggert, Sara Eichau, Claudia Eickoff, Aaron Ellenbogen, Philipp Ellmerer, Inés Esparragosa Vázquez, Alexandre Eusébio, Siobhán Ewert, John Fang, Danielle Feigenbaum, Frédérique Fluchère, Alexandra Foubert‐Samier, Marie Fournier, Anne Fradet, Valérie Fraix, Samuel Frank, Monique Gailitzky, Anne Gaille Corbille, J.M. De La Morena, Carme Brun i Gasca, Thomas Gasser, Caroline Giordana, Ira Goodman, A Gorospe, Marie Goubeaud, David Grabli, Mangone Graziella, Stéphan Grimaldi, Jeffrey M. Gross, Raquel Guimarães‐Costa, Andreas Hartmann, Christian J. Hartmann, Travis Hassell, Robert A. Hauser, Antonio Hernandez, Jorge Hernández‐Vara, Günter U. Höglinger, Christian Homedes, Andrea Horta, J.L. Houéto, Julius Huebl, Jennifer I. Hui, Stuart Isaacson, Joseph Jankovic, Annette Janzen, María José Martí Domènech, X. Joseph, Srinath Kadimi, Silja Kannenberg, Rebecca Kassubek, Maya Katz, Kevin J. Klos, Christopher Kobet, Jennifer Koebert, Patricia Krause, Andrea A. Kühn, Jaime Kulisevsky Bojarsky, Rajeev Kumar, M. Kunz, Lille Kurvits, Kimberly Kwei, Simon Laganiere, Brice Laurens, Johannes Levin, Oren Levy, Patricia L. Witt, Gurutz Linazasoro Cristóbal, Irene Litvan, Karlo J. Lizárraga, Katherine Longardner, Rocío López, Lydia López Manzanares, Sara Lucas Del Pozo, Maria Rosario Luquin Puido, Nijee Luthra, Kelly Lyons, Sylvia Maaß, Gerrit Machetanz, Yolanda Macías, David Maltête, Jorge U Máñez-Miró, Louise‐Laure Mariani, Juan Marín‐Lahoz, Kathrin Marini, Ana Marquès, Gloria Martí‐Andrés, Wassilios G. Meissner, Sara Meoni, Dunia Mon Martinez, Johnson Moon, Elena Moro, Peter Morrison, Christoph Mühlberg, Manpreet Multani, Christine Murphy, Anthony P. Nicholas, Rajesh Pahwa, Antonio Palasis, Heidi Pape, Neepa Patel, Marina Peball, Elizabeth Peckham, Terry Peery, Jesus Perez, Rafael L. Perez, Elmar H. Pinkhardt, Werner Poewe, Elsa Pomies, Cécile Preterre, Joseph Quinn, Olivier Rascol, Philippe Remy, Irene Hegeman Richard, Benjamin Röeben, Jost‐Julian Rumpf, David H. Russell, Hayet Salhi, Daniela Samaniego, Alexandra Samier‐Foubert, Álvaro Sánchez‐Ferro, Emmanuelle Schmitt, Alfons Schnitzler, Oliver Schorr, Julie Schwartzbard, Kerstin Schweyer, Klaus Seppi, Victoria Sergo, Holly A. Shill, Andrew Siderowf, Tanya Simuni, Umberto Spampinato, Ashok Sriram, Natividad Stover, Caroline Tanner, Arjun Tarakad, Carolyn Taylor, Claire Thalamus, Thomas B. Toothaker, Nadège Van Blercom, Nora Vanegas-Arrogave, Lydia Vela, Tiphaine Vidal, Jonathan Vöglein, Ryan R. Walsh, Cheryl Waters, Mirko Wegschneider, Endy Weidinger, Caroline Weill, Gregor Wenzel, Tatiana Witjas, Isabel Wurster, Brenton A. Wright, Milan Zimmermann, Rafael Zuzuarregui, Atieh Bamdadian, Teresa Barata, Sara Belli, Frank Boess, Azad Bonni, Edilio Borroni, Anne Boulay, Markus Britschgi, Valérie Cosson, Christian Czech, Evan Davies, Dennis Deptula, Cheikh Diack, Rachelle S. Doody, Juergen Dukart, Giulia D’Urso, Sebastian Dziadek, Chris J. Edgar, Morgan Farell, Rebecca Finch, Paulo Fontoura, Waltraud Gruenbauer, Andrea Hahn, Štefan Holiga, Michael Honer, Shirin Jadidi, Thomas Kremer, Claire Landsdall, Cecile Paquet Luzy, Marianne Manchester, Maddalena Marchesi, Ferenc Martényi, Meret Martin‐Facklam, Katerina Mironova, Emma Moore, Markus Niggli, Susanne Ostrowitzki, Benedicte Passemard, Agnès Poirier, Anke Post, Megana Prasad, Nathalie Pross, Benedicte Ricci, Ellen Rose, Christoph Sarry, Christine M. Schubert, Jeff Sevigny, Kaycee M. Sink, Nima Shariati, Alexander Strasak, Hannah Staunton, Dylan Trundell, Daniel Umbricht, Lynne Verselis, Annamarie Vogt, Cornelia Weber, Silke Anna Theresa Weber, Stefano Zanigni

Bibliographic record

Venuenpj Digital Medicine · 2025
Typearticle
Languageen
FieldMedicine
TopicParkinson's Disease Mechanisms and Treatments
Canadian institutionsMcGill UniversityCentre for Movement DisordersMontreal General Hospital
FundersProthenaF. Hoffmann-La Roche
KeywordsMotor symptomsSign (mathematics)Parkinson's diseaseMedicinePhysical medicine and rehabilitationOutcome (game theory)DiseaseInternal medicinePsychologyOncologyPhysical therapy

Abstract

fetched live from OpenAlex

Digital health technology (DHT) tools for Parkinson's disease (PD) e.g., smartphones and wearables were used for remote and frequent measurement of motor signs in the phase 2 PASADENA study of the anti-alpha-synuclein monoclonal antibody prasinezumab. 316 early-stage PD participants were randomized to placebo, 1500 mg, or 4500 mg prasinezumab for 52 weeks; placebo participants were re-randomized to prasinezumab for the ensuing 52 weeks. Patients performed daily smartphone motor "active tests", and were passively monitored by smartphone/smartwatch throughout the day over 2 y. Change from baseline analyses censored data at dopaminergic treatment start. Bilateral speeded tapping variability and hand-turning, U-turn speed, passively monitored hand movement power, and summary Simple Sum scores progressed numerically less in prasinezumab-treated vs placebo at week 52. All findings except hand-turning persisted at week 104. DHT sensor-based outcome measures may contribute to quantifying disease progression in clinical research of early-stage, dopaminergic treatment-naïve PD. Clinical Trial Registry Name: ClinicalTrials.gov; Clinical Trial Registry ID: NCT03100149; registered 2017-03-29.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.050
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.027
GPT teacher head0.285
Teacher spread0.258 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations11
Published2025
Admission routes1
Has abstractyes

Explore more

Same venuenpj Digital MedicineSame topicParkinson's Disease Mechanisms and TreatmentsFrench-language works237,207